This study is looking at whether a digital support tool can help people with severe mental illness. Participants receive a study treatment and complete follow-up visits and assessments.
In United Kingdom
Why is this study shown?
This study includes Bipolarity among several conditions.
Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
This study is looking at whether a mental health workshop can help people with severe mental illness. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
In United Kingdom
Why is this study shown?
This study includes Bipolarity among several conditions.
Schizophrenia, BipolarityOtherFrom 18 Years to 99 Years
Countries
United Kingdom
Sponsor
Sheffield Health and Social Care NHS Foundation Trust
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study includes Bipolarity among several conditions.
Schizophrenia, BipolarityDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
Schizophrenia, BipolarityDrug
Countries
Bulgaria, Hungary, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Czech Republic
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Vienna
Why is this study shown?
This study includes Bipolarity among several conditions.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.